Ausgewählte Publikationen

Nach dem Gesetz ist es uns verboten, die pdf-Dateien der letzen Veröffenlichungen auf unserer Webseite zu präsentieren.
Bitte kontaktieren Sie uns
direkt, wenn Sie an einer Neuauflage interessiert sind. Danke.

2014

Müller G, Olschewski J, Stange T, Hjellset VT, Bornstein S, Schwarz PE.
Non-invasive Screening of Diabetes Risk by Assessing Abnormalities of Sudomotor Function.
Exp Clin Endocrinol Diabetes. 2014 May 5. [Epub ahead of print] (PubMed)

Parfentyeva E, Saha S, Hjellset VT, Kopprasch S, Schwarz PE.
Assessment of small C-fiber status for screening of oxidative stress in patients at risk of diabetes.
Horm Metab Res. 2014 Feb 28[Epub ahead of print] (PubMed)

2013

Graessler J, Bornstein TD, Goel D, Bhalla VP, Lohmann T, Wolf T, Koch M, Qin Y, Licinio J, Wong ML, Chavakis T, Xu A, Shevchenko A, Schuhmann K, Schwarz PE, Schulte KM, Patel A, Bornstein SR.
Lipidomic profiling before and after Roux-en-Y gastric bypass in obese patients with diabetes.
Pharmacogenomics J. 2013 Dec 24. [Epub ahead of print] (PubMed)

Dimas AS, Lagou V, Barker A, Knowles JW, Mägi R, Hivert MF, Benazzo A, Rybin D, Jackson AU, Stringham HM, Song C, Fischer-Rosinsky A, Boesgaard TW, Grarup N, Abbasi FA, Assimes TL, Hao K, Yang X, Lecoeur C, Barroso I, Bonnycastle LL, Böttcher Y, Bumpstead S, Chines PS, Erdos MR, Graessler J, Kovacs P, Morken MA, Narisu N, Payne F, Stancakova A, Swift AJ, Tönjes A, Bornstein SR, Cauchi S, Froguel P, Meyre D, Schwarz PE, Häring HU, Smith U, Boehnke M, Bergman RN, Collins FS, Mohlke KL, Tuomilehto J, Quertemous T, Lind L, Hansen T, Pedersen O, Walker M, Pfeiffer AF, Spranger J, Stumvoll M, Meigs JB, Wareham NJ, Kuusisto J, Laakso M, Langenberg C, Dupuis J, Watanabe RM, Florez JC, Ingelsson E, McCarthy MI, Prokopenko I; MAGIC Investigators..
Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity.
Diabetes. 2013 Dec 2. [Epub ahead of print] (PubMed)

Müller G, Parfentyeva E, Olschewsky J, Bornstein SR, Schwarz PE.
Assessment of small fiber neuropathy to predict future risk of type 2 diabetes.
Prim Care Diabetes. 2013 Sep 27. [Epub ahead of print] (PubMed)

Wagner R, Thorand B, Osterhoff MA, Müller G, Böhm A, Meisinger C, Kowall B, Rathmann W, Kronenberg F, Staiger H, Stefan N, Roden M, Schwarz PE, Pfeiffer AF, Häring HU, Fritsche A.
Family history of diabetes is associated with higher risk for prediabetes: a multicentre analysis from the German Center for Diabetes Research.
Diabetologia. 2013 Aug 24. [Epub ahead of print] (PubMed)

Müller G, Weser G, Schwarz PE.
The European perspective of diabetes prevention: the need for individualization of diabetes prevention.
J Endocrinol Invest. 2013 May. (PubMed)

Schwarz PE, Gallein G, Ebermann D, Müller A, Lindner A, Rothe U, Nebel IT, Müller G.
Global Diabetes Survey--an annual report on quality of diabetes care.
Diabetes Res Clin Pract. 2013 Jan 16. [Epub ahead of print] (PubMed)

2012

Schwarz PE.
Diabetes prevention - the global hope on the horizon.
Indian J Med Res. 2012 Nov. (PubMed)

Saha S, Schwarz PE., Bergmann S, Bornstein SR, Graessler J, Kopprasch S
Circulating very-low-density lipoprotein from subjects with impaired glucose tolerance accelerates adrenocortical cortisol and aldosterone synthesis.
Horm Metab Res. 2012 Oct 9. [Epub ahead of print] (PubMed)

Scott RA et al.
No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels.
Diabetes. 2012 Mar 13. [Epub ahead of print] (PubMed)

Blüher S, Markert J, Herget S, Yates T, Davis M, Müller G, Waldow T, Schwarz PE.
Who should we target for diabetes prevention and diabetes risk reduction?
Curr Diab Rep. 2012 Apr. (PubMed)

Schwarz PE, Greaves CJ, Lindström J, Yates T, Davies MJ.
Nonpharmacological interventions for the prevention of type 2 diabetes mellitus.
Nat Rev Endocrinol. 2012 Jan 17. (PubMed)

2011

 

Yates T, Davies MJ, Schwarz PE, Khunti K.
Diabetes prevention: a call to action.
Indian J Med Res. 2011 Nov. (PubMed)

Schwarz PE., Albright AL.
Prevention of type 2 diabetes: the strategic approach for implementation.
Horm Metab Res. 2011 Dec 7 [Epub ahead of print] (PubMed)

Strawbridge RJ et al.
Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.
Diabetes. 2011 Aug 26. [Epub ahead of print] (PubMed)

2010

Schwarz PE.
Public health implications: translation into diabetes prevention initiatives--four-level public health concept.
Med Clin North Am. 2010 Dec 17. [Epub ahead of print] (PubMed)

Schwarz PE, Lindström J.
From evidence to practice--the IMAGE project--new standards in the prevention of type 2 diabetes.
Diabetes Res Clin Pract. 2010 Dec 30. [Epub ahead of print] (PubMed)

Hische M, Luis-Dominguez O, Pfeiffer AF, Schwarz PE, Selbig J, Spranger J.
Decision trees as a simple-to-use and reliable tool to identify individuals with impaired glucose metabolism or type 2 diabetes mellitus.
Eur J Endocrinol.  2010 Aug 6. [Epub ahead of print] (PubMed)

Graessler J, Gruber M, Radke RB, Kopprasch S, Schwarz PE, Kamke W, Bornstein SR, Fischer S.
Type 2 diabetes in octogenarians is associated with decreased low molecular weight adiponectin.
Gerontology. 2010 Jun 11. [Epub ahead of print] (PubMed)

Pajunen P et al.
Quality indicators for the prevention of type 2 diabetes in Europe--IMAGE.
Horm Metab Res. 2010 Apr 13. [Epub ahead of print] (PubMed)

Lindström J et al.
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe.
Horm Metab Res. 2010 Apr 13. [Epub ahead of print] (PubMed)

Paulweber B et al.
A European evidence-based guideline for the prevention of type 2 diabetes.
Horm Metab Res. 2010 Apr 13. [Epub ahead of print] (PubMed)

Tuomilehto J, Schwarz PE.
Primary prevention of type 2 diabetes is advancing towards the mature stage in Europe.
Horm Metab Res. 2010 Apr 13. [Epub ahead of print] (PubMed)

Ingelsson E, Langenberg C, Hivert MF, Prokopenko I, Lyssenko V, Dupuis J, Mägi R, Sharp S, Jackson AU, Assimes TL, Shrader P, Knowles JW, Zethelius B, Abbasi FA, Bergman RN, Bergmann A, Berne C, Boehnke M, Bonnycastle LL, Bornstein SR, Buchanan TA, Bumpstead SJ, Böttcher Y, Chines P, Collins FS, Cooper CC, Dennison EM, Erdos MR, Ferrannini E, Fox CS, Graessler J, Hao K, Isomaa B, Jameson KA, Kovacs P, Kuusisto J, Laakso M, Ladenvall C, Mohlke KL, Morken MA, Narisu N, Nathan DM, Pascoe L, Payne F, Petrie JR, Sayer AA, Schwarz PE, Scott LJ, Stringham HM, Stumvoll M, Swift AJ, Syvänen AC, Tuomi T, Tuomilehto J, Tönjes A, Valle TT, Williams GH, Lind L, Barroso I, Quertermous T, Walker M, Wareham NJ, Meigs JB, McCarthy MI, Groop L, Watanabe RM, Florez JC; MAGIC investigators.
Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans.
Diabetes. 2010 Feb 25. [Epub ahead of print] (PubMed)

2009

Graessler J, Schwudke D, Schwarz PE, Herzog R, Shevchenko A, Bornstein SR.
Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients.
PLoS One. 2009 Jul 15. (PubMed)

Schwarz PE, Li J, Bornstein SR.
Screening for type 2 diabetes in primary care.
BMJ. 2009 Mar 17 (PubMed)

Schwarz PE, Bornstein SR, Hanefeld M.
The future of the metabolic syndrome.
Horm Metab Res. 2009 Feb 12. [Epub ahead of print] (PubMed)